Kinetic, thermodynamic and statistical studies on the inhibition of adenosine deaminase by aspirin and diclofenac

被引:26
作者
Ajloo, Davood [1 ]
Saboury, Ali A.
Haghi-Asli, Niloofar
Ataei-Jafarai, Ghasem
Moosavi-Movahedi, Ali A.
Ahmadi, Mosayeb
Mahnam, Karim
Namaki, Saeed
机构
[1] Damghan Univ Basic Sci, Fac Chem, Damghan, Iran
[2] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Fac Pharamed Sci, Tehran, Iran
[4] Damghan Univ Basic Sci, Fac Math Sci, Damghan, Iran
关键词
adenosine deaminase inhibitors; quantitative structure-activity relationship; QSAR; aspirin; diclofenac; principal component analysis;
D O I
10.1080/14756360701229085
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The kinetic and thermodynamic effects of aspirin and diclofenac on the activity of adenosine deaminase ( ADA) were studied in 50 mM phosphate buffer pH 7.5 at 27 and 37 degrees C, using UV-Vis spectrophotometry and isothermal titration calorimetry ( ITC). Aspirin exhibits competitive inhibition at 27 and 37 degrees C and the inhibition constants are 42.8 and 96.8 mu M respectively, using spectrophotometry. Diclofenac shows competitive behavior at 27 degrees C and uncompetitive at 37 degrees C with inhibition constants of 56.4 and 30.0 mu M, at respectively. The binding constant and enthalpy of binding, at 27 degrees C are 45 mM, 264.5 kJ/mol and 61 mu M, -34.5 kJ/mol for aspirin and diclofenac. Thermodynamic data revealed that the binding process for these ADA inhibitors is enthalpy driven. QSAR studies by principal component analysis implemented in SPSS show that the large, polar, planar, and aromatic nucleoside and small, aromatic and polar non-nucleoside molecules have lower inhibition constants.
引用
收藏
页码:395 / 406
页数:12
相关论文
共 45 条
[1]   TIGHT-BINDING INHIBITORS .4. INHIBITION OF ADENOSINE DEAMINASES BY VARIOUS INHIBITORS [J].
AGARWAL, RP ;
SPECTOR, T ;
PARKS, RE .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (05) :359-367
[2]   Kinetic and structural analysis of the inhibition of adenosine deaminase by acetaminophen [J].
Ataie, G ;
Safarian, S ;
Divsalar, A ;
Saboury, AA ;
Moosavi-Movahedi, AA ;
Ranjbar, B ;
Cristalli, G ;
Mardanian, S .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2004, 19 (01) :71-78
[3]   Enthalpy and enzyme activity of modified histidine residues of adenosine deaminase and diethyl pyrocarbonate complexes [J].
Ataie, G ;
Moosavi-Movahedi, AA ;
Saboury, AA ;
Hakimelahi, GH ;
Hwu, JR ;
Tsay, SC .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2000, 27 (01) :29-33
[4]   IDENTIFICATION OF THE BIOACTIVE ENANTIOMER OF ERYTHRO-3-(ADENIN-9-YL)-2-NONANOL (EHNA), A SEMI-TIGHT BINDING INHIBITOR OF ADENOSINE-DEAMINASE [J].
BAKER, DC ;
HANVEY, JC ;
HAWKINS, LD ;
MURPHY, J .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (10) :1159-1160
[5]   EFFECT OF PH UREA AND GUANIDINE ON ADENOSINE DEAMINASE ISOLATED FROM BOVINE MUCOSA [J].
BRADY, TG ;
OSULLIVA.M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 132 (01) :127-&
[6]   PENTOSTATIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN LYMPHOPROLIFERATIVE DISORDERS [J].
BROGDEN, RN ;
SORKIN, EM .
DRUGS, 1993, 46 (04) :652-677
[7]  
CHECHIK BE, 1981, J IMMUNOL, V126, P1003
[8]  
Cristalli G, 2001, MED RES REV, V21, P105, DOI 10.1002/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO
[9]  
2-U
[10]  
Cronstein BN, 1999, CURR INFLAMMAT RES, P259